Seite - (000152) - in Advances in Neuroimmunology

BrainSci. 2017,7, 11 77. Chizzolini, C.; Dayer, J.M.; Miossec, P. Cytokines in chronic rheumatic diseases: Is everything lack of homeostaticbalance?ArthritisRes. Ther. 2009,11, 246. [CrossRef] [PubMed] 78. Iwasaki,A.;Medzhitov,R.Regulationofadaptive immunitybythe innate immunesystem.Science2010,327, 291–295. [CrossRef] [PubMed] 79. Zhang, J.M.;An, J.Cytokines, inflammation, andpain. Int. Anesthesiol. Clin. 2007,45, 27–37. [CrossRef] [PubMed] 80. Dinarello,C.A. Immunologicalandinflammatory functionsof the interleukin-1 family.Annu.Rev. Immunol. 2009,27, 519–550. [CrossRef] [PubMed] 81. Garlanda,C.;Dinarello,C.A.;Mantovani,A.The interleukin-1 family: Back to the future. Immunity2013,39, 1003–1018. [CrossRef] [PubMed] 82. Pearson,V.L.;Rothwell,N.J.;Toulmond,S.Excitotoxicbraindamage in therat induces interleukin-1beta protein inmicrogliaandastrocytes:Correlationwith theprogressionofcelldeath.Glia1999,25, 311–323. [CrossRef] 83. Dinarello, C.A. Blocking IL-1 in systemic inflammation. J. Exp. Med. 2005, 201, 1355–1359. [CrossRef] [PubMed] 84. Dinarello,C.A. Interleukin1andinterleukin18asmediatorsof inflammationandtheagingprocess.Am. J. Clin.Nutr. 2006,83, 447S–455S. [PubMed] 85. Lu, K.T.;Wang, Y.W.;Wo, Y.Y.; Yang, Y.L. Extracellular signal-regulated kinase-mediated IL-1-induced corticalneurondamageduringtraumaticbrain injury.Neurosci. Lett. 2005,386, 40–45. [CrossRef] [PubMed] 86. Liu,T.;Young,P.R.;McDonnell,P.C.;White,R.F.;Barone,F.C.;Feuerstein,G.Z.Cytokine-inducedneutrophil chemoattractantmRNAexpressed incerebral ischemia.Neurosci. Lett. 1993,164, 125–128. [CrossRef] 87. Grilli,M.;Memo,M.Nuclear factor-kappaB/Relproteins:Apointofconvergenceofsignallingpathways relevant inneuronal functionanddysfunction.Biochem.Pharmacol. 1999,57, 1–7. [CrossRef] 88. Baeuerle,P.A.;Baltimore,D.NF-kappaB:Tenyearsafter.Cell1996,87, 13–20. [CrossRef] 89. Jander,S.; Stoll,G.Differential inductionof interleukin-12, interleukin-18,andinterleukin-1betaconverting enzymemRNAinexperimentalautoimmuneencephalomyelitisof the lewisrat. J.Neuroimmunol. 1998,91, 93–99. [CrossRef] 90. Losy, J.; Niezgoda,A. IL-18 in patientswithmultiple sclerosis. ActaNeurol. Scand. 2001, 104, 171–173. [CrossRef] [PubMed] 91. Fassbender, K.; Mielke, O.; Bertsch, T.; Muehlhauser, F.; Hennerici, M.; Kurimoto, M.; Rossol, S. Interferon-gamma-inducingfactor (IL-18)andinterferon-gammain inflammatoryCNSdiseases.Neurology 1999,53, 1104–1106. [CrossRef] [PubMed] 92. Sims, J.E.; Smith,D.E. The IL-1 family: Regulators of immunity. Nat. Rev. Immunol. 2010, 10, 89–102. [CrossRef] [PubMed] 93. Kremlev, S.G.; Roberts,R.L.; Palmer,C.Differential expressionof chemokines andchemokine receptors duringmicroglialactivationandinhibition. J.Neuroimmunol. 2004,149, 1–9. [CrossRef] [PubMed] 94. Gyoneva, S.; Ransohoff, R.M. Inflammatory reactionafter traumatic brain injury: Therapeuticpotential of targetingcell-cell communicationbychemokines. TrendsPharmacol. Sci. 2015,36, 471–480. [CrossRef] [PubMed] 95. Choi, S.S.; Lee,H.J.; Lim, I.; Satoh, J.; Kim, S.U.Humanastrocytes: Secretomeprofiles of cytokines and chemokines.PLoSONE2014,9, e92325. [CrossRef] [PubMed] 96. Ono,S.J.;Nakamura,T.;Miyazaki,D.;Ohbayashi,M.;Dawson,M.;Toda,M.Chemokines:Roles in leukocyte development, trafficking,andeffector function. J.AllergyClin. Immunol. 2003,111, 1185–1199. [CrossRef] [PubMed] 97. Helmy,A.;Carpenter,K.L.;Menon,D.K.;Pickard, J.D.;Hutchinson,P.J.Thecytokineresponse tohuman traumaticbrain injury: Temporalprofilesandevidence forcerebralparenchymalproduction. J.Cereb. Blood FlowMetab. 2011,31, 658–670. [CrossRef] [PubMed] 98. Helmy,A.;Antoniades,C.A.;Guilfoyle,M.R.;Carpenter,K.L.;Hutchinson,P.J.Principalcomponentanalysis of the cytokine and chemokine response to human traumatic brain injury. PLoSONE 2012, 7, e39677. [CrossRef] [PubMed] 99. Glabinski,A.R.;Tani,M.;Aras, S.; Stoler,M.H.;Tuohy,V.K.;Ransohoff,R.M.Regulationandfunctionof centralnervoussystemchemokines. Int. J.Dev.Neurosci. 1995,13, 153–165. [CrossRef] 142